Loading candles…
Established in 1988 and headquartered in Hyderabad, India, Vivimed Labs Ltd operates as an integrated pharmaceutical company serving global regulated and semi-regulated markets. The company manufactures Active Pharmaceutical Ingredients (APIs), Contract Development and Manufacturing Organization (CDMO) Finished Dosage Formulations, specialty chemicals, and retail branded formulations. It is engaged across the pharmaceuticals, specialty chemicals, and healthcare industries. Vivimed Labs transitioned from its initial role as a contract manufacturer of formulations to a fully integrated participant in the global healthcare sector. The company’s business segments include specialty chemicals and pharmaceuticals, with no stated subsidiaries or notable projects disclosed.
This page is a live market overview for VIVIMED LABS LIMITED (VIVIMEDLAB) on the NSE. As a listed security, VIVIMED LABS LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for VIVIMEDLAB before placing trades on tick2trade.
As of the latest feed, VIVIMEDLAB last traded at ₹5.28 on NSE, down ₹0.1 (1.86%) from the previous close of ₹5.38. Today's session range is ₹5.28 – ₹5.48, against a 52-week band of ₹4.75 – ₹29.4. Traded volume today stands at 23.98K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for VIVIMEDLAB in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether VIVIMEDLAB is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for VIVIMED LABS LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in VIVIMEDLAB. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated VIVIMEDLAB option chain page linked from this overview.
| Results - FY25 |
| To consider and approve the financial results for the period ended December 31, 2025 |
| 13 Feb 2026 |
| Results - FY25 | Vivimed Labs Limited has informed the Exchange that the meeting of the Board of Directors of the Company scheduled to be held on February 13, 2026 To conside… | 13 Feb 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.